ORKA insider plans sale of 28,588 common shares

ORKA has a notice of proposed sale under Form 144 for 28,588 common shares, to be effected through Morgan Stanley Smith Barney LLC Executive Financial Services.

Rhea-AI Filing Summary

ORKA has a notice of proposed sale under Form 144 for 28,588 common shares, to be effected through Morgan Stanley Smith Barney LLC Executive Financial Services. The shares are planned to be sold on July 13, 2026 in connection with an exercise of stock options for cash.

The filing also lists recent Rule 10b5-1 sales by Arjun Agarwal over the prior three months, including multiple transactions in May and June 2026 involving several thousand shares each.

Filing Explained

The filing reports a planned July 13 sale after option exercise; it is not evidence that the sale has occurred or proceeds were received.

The July 13, 2026 Form 144 reports a proposed sale of Oruka Therapeutics common shares after an exercise of stock options, with cash listed as consideration.

The filing does not state that this sale has occurred.

It identifies Morgan Stanley Smith Barney LLC as the broker and lists July 13, 2026 as the sale date.

It also labels four earlier entries for Arjun Agarwal as 10b5-1 sales between May 18, 2026 and June 22, 2026; the supplied definition describes a 10b5-1 plan as a written plan adopted in advance that executes trades on a schedule or formula.

The disclosure therefore establishes a planned disposition and an option-exercise basis for the securities to be sold, but not completed sale proceeds or a quantified change in the company's common-share count.

Key Figures

Proposed shares to be sold: 28,588 shares Shares sold 06/22/2026: 1,587 shares Proceeds 06/22/2026: $128,468.24 +4 more

7 metrics

Proposed shares to be sold 28,588 shares Common shares proposed for sale on July 13, 2026 following stock option exercise

Shares sold 06/22/2026 1,587 shares Rule 10b5-1 sale of common stock on June 22, 2026

Proceeds 06/22/2026 $128,468.24 Dollar amount for 1,587-share Rule 10b5-1 sale on June 22, 2026

Shares sold 06/12/2026 9,459 shares Rule 10b5-1 sale of common stock on June 12, 2026

Proceeds 06/12/2026 $659,507.68 Dollar amount for 9,459-share Rule 10b5-1 sale on June 12, 2026

Shares sold 05/18/2026 10,290 shares Rule 10b5-1 sale of common stock on May 18, 2026

Proceeds 05/18/2026 $607,806.63 Dollar amount for 10,290-share Rule 10b5-1 sale on May 18, 2026

Key Terms

Form 144, Rule 10b5-1 sales, Exercise of Stock Options, Executive Financial Services

4 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Rule 10b5-1 sales regulatory

"10b5-1 Sales for ARJUN AGARWAL 855 Oak Grove Avenue"

Exercise of Stock Options financial

"Common | 07/13/2026 | Exercise of Stock Options | Issuer"

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

FAQ

What does ORKA’s latest Form 144 filing disclose?

The filing discloses a planned sale of 28,588 ORKA common shares on July 13, 2026, related to an exercise of stock options for cash through Morgan Stanley Smith Barney LLC Executive Financial Services.

How many ORKA (ORKA) shares are proposed to be sold on July 13, 2026?

The Form 144 indicates a proposed sale of 28,588 common shares of ORKA on July 13, 2026. The transaction is tied to an exercise of stock options for cash and routed via Morgan Stanley Smith Barney LLC Executive Financial Services.

What recent Rule 10b5-1 sales for ORKA (ORKA) are listed in the Form 144?

The filing lists Rule 10b5-1 sales for Arjun Agarwal, including 1,587 shares on June 22, 2026; 9,459 shares on June 12, 2026; and 10,290 shares on May 18, 2026, among other transactions.

Who is the selling security holder in the ORKA (ORKA) Form 144 transactions?

The filing references 10b5-1 sales for Arjun Agarwal and identifies Morgan Stanley Smith Barney LLC Executive Financial Services as the intermediary for the proposed 28,588-share stock option exercise and sale dated July 13, 2026.

What type of transaction underlies the ORKA (ORKA) shares to be sold?

The Form 144 states that the 28,588 ORKA common shares are tied to an Exercise of Stock Options for cash dated July 13, 2026, with common stock to be sold following that option exercise.

What past ORKA (ORKA) sales amounts are disclosed for Arjun Agarwal?

The filing shows several completed sales, including 1,587 shares for $128,468.24 on June 22, 2026; 395 shares for $27,527.55 on June 15, 2026; and 10,290 shares for $607,806.63 on May 18, 2026, all in ORKA common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/13/2026 - 04:36 PM Accepted by SEC EDGAR 07/13/2026 - 04:36 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002033974
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Oruka Therapeutics, Inc.
SEC File Number	000-22873
Address of Issuer	855 Oak Grove Avenue Suite 100 Menlo Park CALIFORNIA 94025
Phone	6506067910
Name of Person for Whose Account the Securities are To Be Sold	Arjun Agarwal
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	28588	2481152.52	60312101	07/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/13/2026	Exercise of Stock Options	Issuer			28588	07/13/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ARJUN AGARWAL 855 Oak Grove Avenue Suite 100 Menlo Park CA 94025	Common	06/22/2026	1587	128468.24
ARJUN AGARWAL 855 Oak Grove Avenue Suite 100 Menlo Park CA 94025	Common	06/15/2026	395	27527.55
10b5-1 Sales for ARJUN AGARWAL 855 Oak Grove Avenue Suite 100 Menlo Park CA 94025	Common	06/12/2026	9459	659507.68
10b5-1 Sales for ARJUN AGARWAL 855 Oak Grove Avenue Suite 100 Menlo Park CA 94025	Common	05/18/2026	10290	607806.63

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	07/13/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Arjun Agarwal
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)